Profitability
Weight: 25%
D+
43
- 5yr Avg ROIC 1.8%
- Operating Margin Trend +33.86 pp/yr
TMDX
TransMedics Group, Inc.
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
⚠ 3 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a platform & compounding fcf business.
Grade overrides the 30.0 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
23
- 5yr Avg ROE 5.1%
- 5yr Share-Count CAGR 10.1%
Growth Quality
Weight: 25%
A+
100
- 5yr Revenue CAGR 111.5%
- 5yr EPS CAGR 382.2%
- Revenue-Growth Years (5) 5/5
Cash Generation
Weight: 20%
F
0
- 5yr FCF Margin -48.9%
- 5yr FCF/NI Conversion -0.79x
Balance Sheet
Weight: 10%
A-
80
- Net Debt / EBITDA -0.13x
- Interest Coverage (EBIT/Int) 8.80x
- Altman Z-Score 2.38
Stability
Weight: 5%
A-
83
- EPS Volatility (σ/μ) 0.00
- Piotroski F-Score 4
- Negative-Revenue Years (5) 0/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.3 of 4 gurus held; 2 trimmed; 2 full exits.
- Holders
- 3 -1
- Avg Δ position
- -3.1%
- New buys
- 0
- Full exits
- 2
- Dalio sold -100%
- Laffont sold -100%
- Greenblatt decreased -7%